Panagora Asset Management’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,555
Closed -$41K 1540
2022
Q1
$41K Buy
+11,555
New +$41K ﹤0.01% 1510
2021
Q3
Sell
-4,481
Closed -$28K 2068
2021
Q2
$28K Sell
4,481
-10,999
-71% -$68.7K ﹤0.01% 2130
2021
Q1
$70K Hold
15,480
﹤0.01% 2127
2020
Q4
$93K Sell
15,480
-67
-0.4% -$403 ﹤0.01% 1860
2020
Q3
$115K Sell
15,547
-304,654
-95% -$2.25M ﹤0.01% 1749
2020
Q2
$1.28M Sell
320,201
-98,244
-23% -$394K 0.01% 842
2020
Q1
$1.06M Sell
418,445
-351,419
-46% -$893K 0.01% 831
2019
Q4
$2.68M Buy
769,864
+96,504
+14% +$336K 0.01% 676
2019
Q3
$3.12M Buy
673,360
+41,385
+7% +$192K 0.01% 596
2019
Q2
$7.79M Buy
631,975
+176,286
+39% +$2.17M 0.03% 400
2019
Q1
$6.06M Buy
455,689
+35,446
+8% +$471K 0.03% 458
2018
Q4
$3.62M Buy
420,243
+434
+0.1% +$3.74K 0.02% 565
2018
Q3
$3.14M Sell
419,809
-16,141
-4% -$121K 0.01% 675
2018
Q2
$2.6M Sell
435,950
-78,961
-15% -$471K 0.01% 778
2018
Q1
$3.01M Buy
514,911
+115,727
+29% +$676K 0.01% 723
2017
Q4
$2.35M Buy
399,184
+7,810
+2% +$46K 0.01% 811
2017
Q3
$1.97M Buy
391,374
+45,258
+13% +$228K 0.01% 867
2017
Q2
$1.4M Buy
346,116
+155,538
+82% +$628K 0.01% 989
2017
Q1
$1.08M Buy
190,578
+169,610
+809% +$965K ﹤0.01% 1108
2016
Q4
$153K Hold
20,968
﹤0.01% 1831
2016
Q3
$168K Buy
20,968
+19,295
+1,153% +$155K ﹤0.01% 1822
2016
Q2
$15K Hold
1,673
﹤0.01% 2199
2016
Q1
$14K Sell
1,673
-7,337
-81% -$61.4K ﹤0.01% 2176
2015
Q4
$97K Buy
9,010
+7,337
+439% +$79K ﹤0.01% 1809
2015
Q3
$14K Sell
1,673
-3,740
-69% -$31.3K ﹤0.01% 2187
2015
Q2
$131K Sell
5,413
-68,963
-93% -$1.67M ﹤0.01% 1867
2015
Q1
$3.13M Sell
74,376
-5,440
-7% -$229K 0.02% 642
2014
Q4
$2.69M Buy
79,816
+30,657
+62% +$1.03M 0.01% 643
2014
Q3
$1.2M Sell
49,159
-1,713
-3% -$42K 0.01% 959
2014
Q2
$1.5M Sell
50,872
-2,564
-5% -$75.4K 0.01% 920
2014
Q1
$2.36M Buy
53,436
+1,485
+3% +$65.4K 0.01% 816
2013
Q4
$1.99M Buy
51,951
+32,964
+174% +$1.26M 0.01% 873
2013
Q3
$416K Buy
18,987
+5,620
+42% +$123K ﹤0.01% 1421
2013
Q2
$233K Buy
+13,367
New +$233K ﹤0.01% 1555